Koppikar Utpal
Insider CIK 1742696 · INSM Director · FLXN Director · ATRA Chief Financial Officer · CCCC Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| INSM INSMED Inc | A Award | 2026-10-19 | 2026-10-20 | 6,139 | — | — | 6,139 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award deriv | 2026-06-24 | 2026-06-26 | 62,000 | — | $0 | 62,000 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award deriv | 2025-06-18 | 2025-06-20 | 35,500 | — | $0 | 35,500 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award deriv | 2024-06-20 | 2024-06-21 | 32,500 | — | $0 | 32,500 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award deriv | 2023-06-15 | 2023-06-16 | 26,000 | — | $0 | 26,000 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2023-03-02 | 2023-03-06 | 6,871 | $3.63 | $24.9K | 181,978 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | P Buy | 2023-02-08 | 2023-02-10 | 5,667 | $5.60 | $31.7K | 5,667 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2023-02-07 | 2023-02-09 | 2,485 | $5.46 | $13.6K | 188,849 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2022-11-16 | 2022-11-18 | 1,083 | $4.49 | $4.9K | 191,334 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2022-11-16 | 2022-11-18 | 5,172 | $4.49 | $23.2K | 192,417 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2022-08-16 | 2022-08-18 | 5,940 | $5.04 | $29.9K | 197,589 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2022-06-08 | 2022-06-10 | 5,853 | $5.63 | $33.0K | 203,529 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2022-05-17 | 2022-05-19 | 966 | $5.32 | $5.1K | 207,592 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2022-05-17 | 2022-05-19 | 4,616 | $5.32 | $24.6K | 208,558 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award deriv | 2022-03-16 | 2022-03-17 | 41,200 | — | $0 | 41,200 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2022-03-01 | 2022-03-03 | 115,107 | — | $0 | 115,107 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2022-03-01 | 2022-03-03 | 2,272 | $9.86 | $22.4K | 214,665 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2022-03-01 | 2022-03-03 | 1,491 | $9.86 | $14.7K | 213,174 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2022-03-01 | 2022-03-03 | 61,235 | — | $0 | 216,937 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2022-02-07 | 2022-02-09 | 2,496 | $14.46 | $36.1K | 155,702 | SEC↗ |
| FLXN Flexion Therapeutics Inc | D To issuer deriv | 2021-11-19 | 2021-11-19 | 32,000 | — | $0 | 0 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2021-11-16 | 2021-11-18 | 3,655 | $17.12 | $62.6K | 157,714 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2021-08-17 | 2021-08-19 | 3,579 | $12.53 | $44.8K | 161,369 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award deriv | 2021-07-09 | 2021-07-12 | 32,000 | — | $0 | 32,000 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2021-06-08 | 2021-06-09 | 5,820 | $14.06 | $81.8K | 164,948 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2021-05-18 | 2021-05-20 | 3,616 | $14.55 | $52.6K | 168,966 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2021-03-26 | 2021-03-30 | 1,761 | $14.58 | $25.7K | 172,582 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2021-03-02 | 2021-03-04 | 1,461 | $16.74 | $24.5K | 174,343 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2021-03-01 | 2021-03-03 | 68,314 | — | $0 | 68,314 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2021-03-01 | 2021-03-03 | 45,258 | — | $0 | 175,804 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2021-02-08 | 2021-02-09 | 1,759 | $20.39 | $35.9K | 130,546 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2020-11-17 | 2020-11-18 | 1,469 | $19.77 | $29.0K | 132,061 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2020-08-18 | 2020-08-20 | 1,496 | $12.09 | $18.1K | 133,530 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2020-06-09 | 2020-06-10 | 3,924 | $10.18 | $39.9K | 135,026 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2020-05-18 | 2020-05-20 | 1,428 | $11.22 | $16.0K | 137,375 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2020-03-27 | 2020-03-30 | 1,827 | $9.17 | $16.8K | 137,330 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2020-03-01 | 2020-03-03 | 73,750 | — | $0 | 73,750 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2020-03-01 | 2020-03-03 | 66,875 | — | $0 | 139,157 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2020-02-06 | 2020-02-10 | 1,781 | $14.21 | $25.3K | 72,282 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2019-03-26 | 2019-03-27 | 10,000 | — | $0 | 74,063 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2019-02-06 | 2019-02-08 | 34,125 | — | $0 | 34,125 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2019-02-06 | 2019-02-08 | 17,063 | — | $0 | 64,063 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | P Buy | 2018-07-27 | 2018-09-11 | 2,000 | $36.80 | $73.6K | 47,000 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2018-06-07 | 2018-06-07 | 75,000 | — | $0 | 75,000 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2018-06-07 | 2018-06-07 | 45,000 | — | $0 | 45,000 | SEC↗ |